OSX2:F:F-Ossiam Lux - Ossiam US Minimum Variance NR (EUR)

ETF | Others |

Last Closing

USD 270.1

Change

+0.50 (+0.19)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.20 (+0.77%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.36 (+0.71%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.15 (+0.71%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.04 (-0.01%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.38 (+0.71%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

-0.23 (-0.26%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.70 (+0.75%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.09 (+0.61%)

USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

+0.02 (+0.02%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.08 (-0.09%)

USD 49.95B

ETFs Containing OSX2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.54% 78% C+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.54% 76% C+ 66% D+
Trailing 12 Months  
Capital Gain 6.89% 60% D- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.89% 58% F 58% F
Trailing 5 Years  
Capital Gain 43.44% 70% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.44% 70% C- 56% F
Average Annual (5 Year Horizon)  
Capital Gain 6.10% 71% C- 69% C-
Dividend Return 6.10% 70% C- 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.86% 60% D- 80% B-
Risk Adjusted Return 61.91% 89% A- 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike